MedTrace Logo

New Biomarkers Evaluating Ovarian Cancer

NCT01466049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2014-08-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.

Conditions

  • Adnexal Mass

Sponsors & Collaborators

  • Fujirebio Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Diana Dickson · Fujirebio Diagnostics, Inc.

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01466049 on ClinicalTrials.gov